42.26000 EUR
0.66
1.54%
Last update Dec 15, 7:32 PM CET
Main market
Day range
42.26000
43.80000
Previous close
42.92000
Open
43.76000
Access this stock data via API
Subscribe
Soleno Therapeutics Inc.
42.26
0.66
1.54%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 67.0M 25.2M 15.3M 21.5M
Selling general and admin 90.2M 13.5M 9.8M 10.8M
Other operating expenses
Operating income -157.2M -38.7M -25.1M -32.3M
Non operating interest income
Income 10.3M 2.6M 300K 110K
Expense 196.9K 0 0
Other income expense -2.8M -2.9M 742K 1.2M
Pretax income -149.9M -39.0M -24.1M -30.9M
Tax provision
Net income -149.9M -39.0M -24.1M -30.9M
Basic EPS -4.4 -2.4 -2.9 -5.8
Diluted EPS -4.4 -2.4 -2.9 -5.8
Basic average shares 34.2M 17.2M 8.7M 5.5M
Diluted average shares 34.2M 17.2M 8.7M 5.5M
EBITDA -145.2M -34.1M -22.8M -31.5M
Net income from continuing op. -149.9M -39.0M -24.1M -30.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 40 minutes

14:19
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).